1. Home
  2. AMCX vs NAGE Comparison

AMCX vs NAGE Comparison

Compare AMCX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$6.80

Market Cap

331.2M

ML Signal

HOLD

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$4.66

Market Cap

386.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
NAGE
Founded
1980
1999
Country
United States
United States
Employees
N/A
117
Industry
Cable & Other Pay Television Services
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.2M
386.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AMCX
NAGE
Price
$6.80
$4.66
Analyst Decision
Sell
Strong Buy
Analyst Count
5
3
Target Price
$7.00
$16.00
AVG Volume (30 Days)
395.8K
1.4M
Earning Date
05-08-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
N/A
EPS
1.66
N/A
Revenue
$2,311,801,000.00
N/A
Revenue This Year
N/A
$20.75
Revenue Next Year
N/A
$19.96
P/E Ratio
$4.01
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$4.39
52 Week High
$10.28
$14.66

Technical Indicators

Market Signals
Indicator
AMCX
NAGE
Relative Strength Index (RSI) 33.99 36.89
Support Level $5.84 N/A
Resistance Level $8.19 $5.32
Average True Range (ATR) 0.31 0.30
MACD -0.12 -0.00
Stochastic Oscillator 10.66 18.35

Price Performance

Historical Comparison
AMCX
NAGE

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: